Data / Form D filings / Illexcor Therapeutics, Inc.
Illexcor Therapeutics, Inc.: Form D filing
Illexcor Therapeutics, Inc., a biotechnology company in Henrico, VA, filed a Form D with the SEC in 2026. The latest, on May 8, 2026, reports $13 million sold of a $69 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11924 Evening Loop, Henrico, VA, 23233
- Phone
- (650) 935-5772
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2132799
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | New notice | $69,000,000 | $13,000,000 | $56,000,000 | 6 | Apr 15, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew N Fleischman | Executive Officer, Director | |
| Timothy E Ladin | Executive Officer | |
| Giovanni Mariggi | Director | |
| Maneka Mirchandaney | Director | |
| Ted Love | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Illexcor Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.